Pharmacy benefit management

Verona Pharma strengthens commercialization leadership team

Retrieved on: 
Wednesday, August 24, 2022
Circassia Group, Salix Pharmaceuticals, Commercial, VRNA, Associate, Bachelor of Liberal Studies, Iowa State University, Degenerative disease, US Foods, Liberal arts education, Maintenance, New Drug Application, Chronic obstructive pulmonary disease, Head, Food, Senior, BLS, Pharmacy benefit management, Cystic fibrosis, Market access, GLOBE, Nasdaq, Company, Therapy, PBM, Abbott Laboratories, Business, Payment, Marketing, Laboratory, Acquisition, Communication, Pharmaceutical industry, Speech, West Chester University

LONDON and RALEIGH, N.C., Aug. 24, 2022 (GLOBE NEWSWIRE) -- Verona Pharma plc (Nasdaq: VRNA) (Verona Pharma or the Company), a clinical-stage biopharmaceutical company focused on respiratory diseases, continues its preparation for commercialization with appointments of Matthew Casbon, Vice President of Sales, Marketing and Training, and Matthew Rysavy, Vice President of Market Access and Trade.

Key Points: 
  • LONDON and RALEIGH, N.C., Aug. 24, 2022 (GLOBE NEWSWIRE) -- Verona Pharma plc (Nasdaq: VRNA) (Verona Pharma or the Company), a clinical-stage biopharmaceutical company focused on respiratory diseases, continues its preparation for commercialization with appointments of Matthew Casbon, Vice President of Sales, Marketing and Training, and Matthew Rysavy, Vice President of Market Access and Trade.
  • Chris Martin, Senior Vice President of Commercial, said: We are very pleased to welcome Mr. Casbon and Mr. Rysavy to Verona Pharma at this exciting time of Company growth and progression.
  • Mr. Casbon brings over 25 years of commercial healthcare experience to Verona Pharma.
  • Prior to Verona Pharma, Mr. Rysavy served as Head of Market Access and Trade at BioDelivery Sciences International, where he was responsible for building the Market Access team to support existing and launch products.

Florida Cancer Specialists & Research Institute Defines Optimal Performance Metrics for Pharmacies Dispensing Oral Oncology Medications

Retrieved on: 
Friday, August 12, 2022
ASCO, Pharmacy, FCS, Medicare, GLOBE, Community Oncology Alliance, Senior, Cancer, Â, Pharmacy benefit management, LLC, U.S. News & World Report, Pharmacy technician, Communication, Society, American Society of Clinical Oncology, Compliance, Health, American Journal, Patient, Associate Director of National Intelligence and Chief Information Officer, Therapy, Education, PBM, Conditional sentence, News, COA, Immunotherapy, Doctor of Pharmacy, Behavioral health outcomes management, Physician, MD, University of Florida Cancer and Genetics Research Complex, Reward, Medicine, Pharmaceutical industry, Hospital, Bachelor of Pharmacy, Pharmacist

Entitled, Defining Appropriate Quality Performance Metrics for Pharmacies Dispensing Oral Oncology Therapies, the authors detail proven, predictive markers for successfully managing the care of cancer patients prescribed these specialty drugs.

Key Points: 
  • Entitled, Defining Appropriate Quality Performance Metrics for Pharmacies Dispensing Oral Oncology Therapies, the authors detail proven, predictive markers for successfully managing the care of cancer patients prescribed these specialty drugs.
  • Oral oncolytics today play a major role in the treatment of patients with many types of cancers, offering clinical benefits and patient conveniences as compared to intravenously administered medications.
  • About Florida Cancer Specialists & Research Institute, LLC: (FLCancer.com)
    Recognized by the American Society of Clinical Oncology (ASCO) with a national Clinical Trials Participation Award, Florida Cancer Specialists & Research Institute (FCS) offers patients access to more clinical trials than any private oncology practice in Florida.
  • The majority of new cancer drugs recently approved for use in the U.S. were studied in clinical trials with Florida Cancer Specialists participation.

House Rx to Launch Specialty Drug Dispensing Inside Rheumatology Clinics By Partnering with Three Leading Practices

Retrieved on: 
Wednesday, August 3, 2022
CFO, Physician, Quality of life, Australian Rheumatology Association, SAN, DO, Patient, Consultant, Rheumatology, Multimedia, Health, Private practice, Pharmacy, Adult, Technology, Research, AOCC, House, Pharmacy benefit management, Entrepreneurship, Pharmacy technician, Arthritis, Nursing, CEO, Caregiver, Pharmacist, Partnership, MID, Population, Pharmaceutical industry, Medicine

SAN FRANCISCO, Aug. 3, 2022 /PRNewswire/ --House Rx, the platform for medically integrated dispensing of specialty medications, announced today it has partnered with three new rheumatology clinics to integrate in-house specialty drug dispensing also known as medically integrated dispensing (MID) into the clinics' operations.

Key Points: 
  • SAN FRANCISCO, Aug. 3, 2022 /PRNewswire/ --House Rx, the platform for medically integrated dispensing of specialty medications, announced today it has partnered with three new rheumatology clinics to integrate in-house specialty drug dispensing also known as medically integrated dispensing (MID) into the clinics' operations.
  • While MID has grown in oncology, House Rx's partnership with these practices is one of the first to bring the model to rheumatology care.
  • "It's very exciting to partner with key thought leaders in rheumatology to bring medically integrated dispensing to this specialty," said Ogi Kavazovic, Co-Founder and CEO of House Rx.
  • By bringing specialty dispensing into the physician's office, the partnership with House Rx aims to dramatically improve the specialty medication experience for patients.

Araya Partners with Levrx to Deliver Members a Virtual Pharmacist

Retrieved on: 
Wednesday, July 13, 2022
Technology, Compliance, Pharmacy, Prescription, Pharmacy benefit management, Patient, Consultant, CEO, Insurance, Time, Araya, Trust, Partnership, TPA, Online shopping, Management, Health insurance

LATHAM, N.Y., July 13, 2022 /PRNewswire/ -- Araya announces a strategic partnership with Levrx Technology Inc. to help Araya clients and members save money and better navigate the complex world of prescriptions with one trusted mobile app.

Key Points: 
  • Araya is committed to delivering a transparent and painless pharmacy experience, which is why they have partnered with Levrx to deliver "Clara", Araya's virtual pharmacist app.
  • "Through our partnership, Araya members can better understand and engage with the prescription programs that help control costs," said Vikram Agrawal, President & CEO at Levrx.
  • "Our goal isto make the prescription process as affordable and simple as possible," says Vikash Agrawal, Executive Chairman at Levrx.
  • "By embracing our technology, Araya improves their members' prescription experience and empowers them to combat the rising costs."

New pharmacy benefits manager, Grane PBM, offers PACE organizations robust analytics, regulatory support for cost-savings and enhanced participant outcomes

Retrieved on: 
Wednesday, June 29, 2022
Pharmacy benefit management, Senior, PACE, National, Medicare, Trust, Compliance, Formulary, Organization, Industry, PBM, Pharmacy, NPA, Information technology, Renewable energy

Through the provision of meaningful data, compliance support, and access to extensive discounts, Grane PBM allows PACE organizations to enjoy cost-effective and robust Pharmacy Benefits Management backed by extensive experience and industry-leading operational expertise.

Key Points: 
  • Through the provision of meaningful data, compliance support, and access to extensive discounts, Grane PBM allows PACE organizations to enjoy cost-effective and robust Pharmacy Benefits Management backed by extensive experience and industry-leading operational expertise.
  • Grane PBM provides comprehensive Part D administration services for PACE organizations , supported in part through its real-time analytics platform.
  • "The role of PBM services in PACE organizations is becoming increasingly more important and complex," said John Baker, Senior Vice President, Grane PBM.
  • Organizations looking for comprehensive support managing their formularies and navigating regulatory requirements should consider Grane PBM for their benefits management.

TELUS Health releases annual Health Drug Data Trends Report 2022: Pandemic side effects include rise in medications for depression and ADHD

Retrieved on: 
Wednesday, June 22, 2022
Solution, HBM, Infection, COVID-19, Pharmacist, Prescription, Technology, Consultant pharmacist, Lisdexamfetamine, Insurance, Efficiency, Depression, Cancer, Adoption, Narcolepsy, Mental health, PBM, Rheumatoid arthritis, Telus Health, Physician, Methylphenidate, Health, TELUS, Patient, Diagnosis, Pharmacy benefit management, Dentist, Psoriasis, Attention deficit hyperactivity disorder, GLOBE, Health insurance, Pharmaceutical industry, Atlantic Canada, ADHD

The report shows a noticeable increase in ADHD medication and antidepressants in 2021.

Key Points: 
  • The report shows a noticeable increase in ADHD medication and antidepressants in 2021.
  • With work-from-home and hybrid workstyles now the norm, it is clear that the pandemic created unique challenges for Canadians, impacting both their mental and physical health, said Shawn OBrien, Principal, Data Enablement and HBM Product, TELUS Health.
  • Five years ago, medications like Vyvanse and Concerta, used to treat neurodivergent-related disorders such as ADHD and narcolepsy, ranked 10th, while in 2021, these medications surpassed cancer medications.
  • TELUS Health is a leader in digital health technology, providing virtual care, home health monitoring, electronic medical and health records, benefits and pharmacy management, and personal emergency response services.

Frier Levitt Obtains Arbitration Award Against Caremark Arising from Improper DIR Fees

Retrieved on: 
Tuesday, June 21, 2022
PBM, How I Braved Anu Aunty and Co-Founded a Million Dollar Company, Contract, Remuneration, FTC, DIR, Company, Centers for Medicare & Medicaid Services, Pharmacy, Arbitral tribunal, PDP, Prabhu, Medicare Part D, Pharmacy benefit management, CMS, Hospital, Ageing, District court, HIV, District, Patient, Medicine, Center, Sale, Practice of law, Health insurance, Medicare, Caremark

Frier Levitt obtained an Arbitration Award on behalf of the specialty pharmacy of over $3.6 Million.

Key Points: 
  • Frier Levitt obtained an Arbitration Award on behalf of the specialty pharmacy of over $3.6 Million.
  • Frier Levitt prevailed on all counts, including breach of contract, with the Arbitrator ordering the return of 100% of the DIR fees recouped from Mission Wellness, plus attorneys' fees and interest, as well as a stern caution about future DIR fee assessment.
  • Frier Levitt filed a petition to confirm the unpaid Arbitration Award in the United States District Court for the District of Arizona.
  • The victory against Caremark and SilverScript provides hope to independent pharmacies that wish to challenge PBM DIR fees.

PATIENTS WITH CHRONIC DISEASE ON CAPITOL HILL TODAY APPEALING FOR ACCESSIBLE AND AFFORDABLE HEALTH CARE

Retrieved on: 
Wednesday, June 15, 2022
Capitol Hill, FDA, Decision-making, View, Insurance, Black Lung Benefits Act of 1972, Congress, Health policy, Senior, Policy, Shoulder, Caregiver, Food, Patient, Pharmacy benefit management, Multimedia, Food and Drug Administration Modernization Act of 1997, Conditional sentence, Health insurance, Pharmaceutical industry, Medical device

Patients and caregivers are meeting with policymakers to appeal for increased transparency in health care and affordability of treatments.

Key Points: 
  • Patients and caregivers are meeting with policymakers to appeal for increased transparency in health care and affordability of treatments.
  • Patients are asking for support for the following policy priorities that will improve access to care:
    Safe Step Act of 2021 (H.R.
  • Patients Rising Now works with patients to advocate for access to treatments, innovations and care they need.
  • Its programming efforts focus on educating patients about the legislative process and empowering them to advocate for reforms to advance patient access, affordability, and transparency in health care.

NCPA Strongly Supports Senate Bill Empowering FTC Action Against PBMs

Retrieved on: 
Tuesday, May 24, 2022
Pharmacy benefit management, MBA, Small business, Computer security, Patient, PBM, Consumer protection, Association, Federal Trade Commission, Pharmacy, Interstate Commerce Committee, Legislation, Community, NCPA, Congress, Human, FTC, Commerce, Cantwell, Senate, GLOBE, Healthcare

The bill would give the Federal Trade Commission and state attorneys general the ability to penalize and/or initiate legal action against pharmacy benefit managers for certain unfair or deceptive business practices in the commercial space.

Key Points: 
  • The bill would give the Federal Trade Commission and state attorneys general the ability to penalize and/or initiate legal action against pharmacy benefit managers for certain unfair or deceptive business practices in the commercial space.
  • Were proud to endorse their latest effort, the Pharmacy Benefit Manager Transparency Act, and will work to help it advance.
  • The Pharmacy Benefit Manager Transparency Act, which falls under the Commerce Committees jurisdiction, is a natural next step forward in the legislative process.
  • Community pharmacies are rooted in the communities where they are located and are among America's most accessible health care providers.

New Poll Highlights Minority Populations’ Healthcare Experiences, Priorities, and Solutions

Retrieved on: 
Wednesday, May 11, 2022
Public Policy, Government, Seniors, White House, Federal Government, General Health, Health, Other Policy Issues, Consumer, Other Health, Population, Health care, Color, Health equity, Policy, Medicine, Capitol Hill, Voting, Safety, Pharmacy benefit management, Patient, PBM, Caregiver, Organic, Family, Clinical trial, Health, Human, Congress, Science, Housing, CEO, Research, Pharmacy, Medical device, Health insurance, Pharmaceutical industry, Ageing

The poll also highlights what minority populations want lawmakers to prioritize for addressing healthcare costs.

Key Points: 
  • The poll also highlights what minority populations want lawmakers to prioritize for addressing healthcare costs.
  • Key takeaways from the poll include:
    Half of Voters of Color Experience Barriers To Care When It Comes To Their Health Care.
  • Voters of Color Support Solutions to Healthcare Costs That Increase Transparency and Improve Access For Vulnerable Communities.
  • This recent poll reveals the disheartening truth of Americas healthcare structure and how its failing minorities daily.